Live feed
·
INSIDERFiling
Zevra Therapeutics Inc. logo

SVP, Finance & Corp Controller Sangiovanni Timothy J. sold $15,442 worth of shares (1,750 units at $8.82) and converted options into 17,999 shares, increasing direct ownership by 99% to 32,590 units (SEC Form 4)